Nunzia Pharmaceutical Corporation Stock Other OTC
Equities
NUNZ
US67097W1027
Pharmaceuticals
Financials (USD)
Sales 2020 | - | Sales 2021 | - | Capitalization | 170M |
---|---|---|---|---|---|
Net income 2020 | -9M | Net income 2021 | -78M | EV / Sales 2020 | - |
Net cash position 2020 * | - | Net Debt 2021 | 97.31K | EV / Sales 2021 | - |
P/E ratio 2020 |
-94.8
x | P/E ratio 2021 |
-2.54
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 18.04% |
Managers | Title | Age | Since |
---|---|---|---|
Sara Gonzales
CEO | Chief Executive Officer | 51 | - |
President | 68 | 08-12-31 | |
Shujie Cui
CTO | Chief Tech/Sci/R&D Officer | 62 | 19-12-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
President | 68 | 08-12-31 | |
Shujie Cui
CTO | Chief Tech/Sci/R&D Officer | 62 | 19-12-04 |
Sara Gonzales
CEO | Chief Executive Officer | 51 | - |
1st Jan change | Capi. | |
---|---|---|
+25.24% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+12.98% | 233B | |
+5.20% | 201B | |
-10.27% | 193B | |
-12.26% | 143B | |
-6.47% | 144B |